Table 1 Characteristics of included primary studies showing dual contraceptive utilization and determinants among HIV positive women in Ethiopia, systematic review and meta-analysis, 2020
Authors | Year of publication | Region | Study design | Sample size | Response rate (%) | Prevalence (95%CI) | Quality |
|---|---|---|---|---|---|---|---|
Abay et al. [13] | 2020 | Amhara | C/S | 563 | 98 | 28.8 (26.83,30.77) | Low risk |
Reta et al. [14] | 2019 | Amhara | C/S | 619 | 98.25 | 13.2 (11.72,14.68) | Low risk |
Kebede et al. [15] | 2015 | Amhara | C/S | 420 | 99.04 | 26.7 (24.77,28.63) | Low risk |
Egzeabher et al. [16] | 2015 | Amhara | C/S | 335 | 98.5 | 19 (17.29,20.71) | Low risk |
Tewabe et al. | 2018 | Amhara | C/S | 308 | 100 | 26 (24.09,27.91) | Low risk |
Asfaw et al. [17] | 2014 | AA | C/S | 1418 | 100 | 18 (16.32,19.68) | Low risk |
Demissie et al. [18] | 2015 | Oromia | C/S | 357 | 100 | 32 (29.96,34.04) | Low risk |
Sufa et al. [19] | 2013 | Oromia | C/S | 461 | 98.9 | 22.4 (20.58,24.22) | Low risk |
Polis et al. [20] | 2014 | Oromia | C/S | 395 | 93.2 | 17 (15.36,18.64) | Low risk |
Dereje et al. [21] | 2019 | Oromia | C/S | 323 | 94.1 | 59.5 (57.36,61.64) | Low risk |
Feyissa et al. [22] | 2020 | Oromia | C/S | 360 | 100 | 17 (15.36,18.64) | Low risk |
Tesfaye et al. [23] | 2014 | Oromia | C/S | 403 | 99.5 | 31.9 (29.86,33.94) | Low risk |
Gebrehiwot et al [24] | 2017 | Tigray | C/S | 331 | 97.9 | 15.7 (14.11,17.29) | Low risk |
Kalayu [25] | 2019 | Tigray | C/S | 632 | 100 | 45.2 (43.03,47.37) | Low risk |
Melaku et al. [26] | 2014 | Tigray | C/S | 964 | 100 | 14 (12.48,15.52) | Low risk |
Berhane.et al. [27] | 2013 | Tigray | C/S | 364 | 99.2 | 21.6 (19.80,23.40) | Low risk |
Assefa et al. [28] | 2014 | Benishangul | C/S | 404 | 100 | 40.9 (38.75,43.06) | Low risk |
Markos et al. [29] | 2019 | SNNP | C/S | 269 | 95.9 | 28.3 (26.34,30.26) | Low risk |
Meseret et al. [30] | 2015 | SNNP | C/S | 243 | 98.78 | 19.8 (18.06,21.54) | Low risk |